CDXC Message Board Post 9184846 | ChromaDex Corporation
home / stock / cdxc / cdxc message board
technur
(investorshub)
Posted on: Feb/25/2021 20:32:01
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=162147659
Whichever cause, my account balances are loving this.
News, Short Squeeze, Breakout and More Instantly...
-
Clinical study results demonstrated that Niagen IV had no adverse side effects, provided superior tolerability, and a 75% shorter infusion time, with blood NAD+ levels peaking sooner and higher three hours post-infusion as compared to NAD+ IV. The U.S. FDA authorized nicotinamide riboside...
-
Shares of GameStop Corp. (NYSE:GME) fell sharply during Friday's session after the company released worse-than-expected first-quarter results ...
-
ChromaDex plans to conduct additional studies on NRC in anticipation of filing for an Investigational New Drug Application (IND) for the treatment of AT ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD + ) and healthy aging research, ...